SyncoPol DL2001 is a Polypropylene glycol with hydroxyl value in range 54-58 mgKOH/g and molecular weight ~2,000 g/mol. The product has low viscosity in range 290-340 cPs at 25°C and functionality ~2.0. The low viscosity of SyncoPol DL2001 has good flowability, which is widely used as a blending polyol in rigid and semi-rigid foam formulation.
SyncoPol® DL2001 is polyether polyol designed for the production of polyurethane foam for Coatings, Adhesives, Sealants, Elastomers and blends polyol for foam system.
Product can be used in combination with other polyols, and additives in order to improve flexibility of foam and adhesion property. Its obtain a good combination of process ability, cost economics and good properties of final product.
Main application advantages of the product SyncoPol® DL2001:
recommended polyol for improving flowability and flexibility of foam surface in rigid and semi-rigid polyurethane foams;
it is used as viscosity-reducing additive in formulated polyol;
enhance adhesion property of polyurethane foam.
Products made based on SyncoPol® DL2001 have excellent in foam quality. Based on the optimally developed manufacturing process, this polyol is shown very good foam performance in both PUR system.
Poly (propylene) glycol, Polypropylene based polyol, Polypolyene glycol, Polypolyene polyol.
Manufacturer: IRPC Polyol Co.,Ltd.
IRPC POLYOL Co., Ltd. is a joint venture between PCC Rokita SA and IRPC Public Ltd. The area of the Company's operations are the markets of South East Asia, China and India. Its main scope of activity is the production and distribution of polyols.
All the above information related to the product are provided according to the best knowledge of the manufacturer and published in good faith. However, the manufacturer does not guarantee the information and contents of this document are complete and accurate, and shall not be liable for the results of using them. The user is obliged to verify and confirm the information and contents of this documentation on his/her own. The manufacturer reserves the right to change the content of this document at any time without stating reasons of such changes.
Subscribe to receive information about new products on the Product Portal and commercial information about the PCC Capital Group
By continuing to use our website, you are agreeing to the placement of cookies or similar technologies on your device for functional, statistical and marketing purposes. You can modify or withdraw your consent at any time in your browser settings. Learn more